Our team is uniquely composed of senior consultants with life sciences background recruited from investment banking and financial advisory firms. Our experts in residence can bring significant sector knowledge and connections within the Pharma/MedTech industry.

The strategic advisory and the financial advisory teams of Bionest also work in close ties bringing to the client one-stop-shop advisory solutions, which are often useful in our assignments. For more information about the Bionest’strategic team: http://bionest.com/company/team/

Bionest Partners Finance has also developed partnerships with foreign Corporate & business development advisory firms allowing an easy access to most emerging markets.

Georges-David Medina 
Pharm D, CEFA

  • Georges-David founded Bionest Partners Finance in 2006 to develop corporate finance advisory services in close ties with Bionest Partners.
  • He completed over 100 Corporate Finance assignments amidst Pharma and Biotech European and North-American companies.
  • Prior to BPF, Georges-David was an equity research analyst at Exane, Natexis Bleichroeder and Bryan Garnier where he was in charge of European mid and big-sized Pharma coverage.
  • He is Pharm Doctor and graduated from HEC.

Damien Choplain (External consultant)
Pharmaceuticals

Damien joined BPF in 2011, he is a senior consultant and analyst, with excellent modeling, financing and programing skills, and has worked in various financial advisory assignments.
Before joining BPF, Damien has worked within Credit Agricole CIB and equity analyst at BDL Capital Management.
He is graduated from CPE Lyon and EM Lyon

Caroline Valldecabres (External consultant)
Polytech Sophia, ESSEC

Caroline joined BPF in 2015, she has a 5 year sell side equity analyst in charge of Pharma/Biotech coverage at Societe Generale and Oddo Securities.
She’s also a former junior analyst at SGAM Alternative Investments.
Caroline is graduated from Polytech (Sophia Antipolis) and ESSEC.

Claude Allary,
Biotechnology/Vaccines, Senior Partner

Claude co-founded Bionest Partners in 2003.
Before joining Bionest Partners, Claude was Vice President at ISO Healthcare (1998-2002) and Senior Consultant at Arthur D. Little (1991-1998).
Claude also held several positions in the industry at Glaxo PLC International, Rhone Poulenc Santé and Park Davis. Claude is graduated from ESSEC.

Alain Gilbert
Pharmaceuticals

Alain co-founded Bionest Partners in 2003 after a 30-year career in the life sciences and healthcare industry.
Over this time, Alain held a.z number of top executive management positions around the globe with pharma and device companies such as Abbott Laboratories and Medtronic.
Alain also led innovative companies at the commercial stage, notably as a European founder of Biogen where he was responsible of the launch of Avonex.
Alain offers an unique combination of experience as a leader and manager of businesses, he also served as board member of many European biotech companies.

Philippe Moreau
Animal Health

Philippe Moreau is founder of Mediproductions, a marketing and communication company dedicated to the veterinary clinic that he developed internationally through new product launches and licensing agreements with leading animal health companies (Idexx, Merial, Virbac).
He is Past President of the NAVC (North American Veterinary Conference) and has given more than 200 lectures and training sessions.
Philippe is a veterinary Doctor and graduated from University of Liège (Belgium) and Purdue University (Texas).

Richard Borgi
Medtech

Richard is both entrepreneur and hospital surgeon.
He was interim CEO of several medtech companies (Coldway, MedTech, Gloster, Praxim, etc…) and held advisory positions to private equity funds.
Richard has also been appointed CEO of SATT Nord, a public funding organization with 63M€ under management.
He published in his career over 45 articles in orthopaedics, traumatology and biomecanic.
Richard is graduated from the Medicine university of Limoges and INSEAD.